Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134115) titled 'Observation of the time of symptom remission in patients with positive symptoms in acute phase of schizophrenia or bipolar disorder manic episode with olanzapine mouth lysis' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Xi 'an Mental Health Center
Condition:
Schizophrenia Bipolar manic episodes
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-01-04
Target Sample Size: Use olanzapine mouth dissolved film:5209;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=240155
Published by HT ...